CVS Health Corporation (CVS)

CVS Health commits $20B to build an open health platform, joining tech giants in a push to streamline patient care access nationwide.

July saw strong market gains, especially in tech, but finding bargains is tough as indices approach all-time highs. I focused July investments on high-yield BDCs like OBDC, MFIC, and BXSL, maintaining...

Investors with an interest in Medical Services stocks have likely encountered both CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors?

Investors love dividend stocks, especially those with high yields, because they provide a substantial income stream and offer significant total return potential.

CVS appears well-poised on strong Q2 revenue growth, raised full-year guidance and momentum in key healthcare segments.

Top-ranked stocks Hasbro (HAS), Carnival (CCL), CVS Health (CVS), Newmont (NEM) and SoFi Technologies (SOFI) are likely to beat on the bottom line in their upcoming releases.

CVS Health Corporation (NYSE:CVS ) Q2 2025 Earnings Call July 31, 2025 8:00 AM ET Company Participants a - Corporate Participant v - Corporate Participant Brian O. Newman - Executive VP & CFO J.

STNE, CVS, KT, KB and USNA stand out in August for low P/B ratios and strong growth forecasts, making them value stock contenders.

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

CVS Health boosts 2025 EPS guidance again as Health Care Benefits and PBM businesses drive growth.